SUMMARY Lysosomal enzyme activities were studied in cells derived from the following types of leukaemia: chronic myeloid, acute myeloid, acute myelomonocytic, acute monocytic, non-T, non-B cell acute lymphoblastic, T-cell acute lymphoblastic, B-cell chronic lymphocytic and T-cell chronic lymphocytic. Activities of f3-hexosaminidase and a-mannosidase were significantly higher in cells from acute monocytic and acute myelomonocytic leukaemias, and somewhat higher in the other myeloid leukaemias, when compared-with control granulocytes. Activities of i3-bexosaminidase, a-mannosidase, a-fucosidase, ,3-glucuronidase and acid phosphatase were markedly lower in B cells of chronic lymphocytic leukaemia when compared with control or other leukaemic lymphoid cells. On isoelectric focusing abnormal patterns of 13-hexosaminidase, amannosidase and /3-glucuronidase activities were commonly found in myeloid and non-T, non-B cell leukaemias. All patients with acute myeloid leukaemia exhibited a relative decrease in the B form ofg,-hexosaminidase activity. The results described show that studies on lysosomal enzymes may assist in the classification of different types of leukaemia.
Recognition of the leukaemic cell type is crucial to the diagnosis, management and prognosis of different types of the disease. In the leukaemias not only cell type but stage of differentiation must be assessed. Classification of the leukaemic cell has generally rested on its morphological, histochemical and immunological characteristics. '`Such studies may be complemented by the recognition of certain biochemical markers24 and specific activities of a number of enzymes including terminal deoxynucleotidyl transferase, adenosine deaminase and 5'nucleotidase may be helpful. Studies on lysosomal enzymes have been mainly cytochemical and acid phosphatasel and oa-naphthyl acetate esterase6 may provide valuable T cell markers. Quantitative assays of lysosomal enzyme activity may also produce useful data, although only limited reports have appeared so far. Low levels of ,3-hexosaminidase and 13-glucuronidase activity have been reported`9 in B-CLL lymphocytes compared with normal or T-CLL lymphocytes. In other reports where activities of a number of lysosomal hydrolases were studied' " in cells from patients with different types of leukaemia various changes were noted, in particular high aAccepted for publication 6 April 1983 mannosidase activities in the non-lymphoid forms of leukaemia.
Previous studies on childhood lymphoblastic leukaemia have demonstrated abnormal patterns of lysosomal enzyme expression in non-T, non-B lymphoblasts after enzyme separation by ion exchange chromatography'2 '" or isoelectric focusing.'4 Such subtle changes may also be expressed in adult forms of leukaemia and when combined with specific enzyme activities may significantly assist in cell classification. The present report is based on studies on 56 adults with eight forms o-f leukaemia and it is suggested that such studies will assist in the classification of leukaemias.
Material and methods
Fifty-six adults were studied at presentation with various forms of leukaemia. Patients were classified using standard histochemical and immunological techniques3 which included the following parameters:
terminal deoxynucleotidyl transferase, Ia (HLA-Dr) antigen, sheep E "rosettes", non-specific esterase, acid phosphatase, chloroacetate esterase, and reactivity with the following monoclonal antibodies, OKT3, OKT4, OKT6, OKT8, OKM1 (Orthodiagnostics Ltd) and MO2, J5 (Coulter Electronics Ltd). From these criteria patients were classified as Correlation oflysosomal enzyme abnormalities in variousforms ofadult leukaemia Control leucocytes were separated from heparinised peripheral blood, using Ficoll-Paque sedimentation for lymphocytes'" and dextran (Dextraven 110, Fisons Ltd) sedimentation for granulocytes. Leukaemic cells were collected either by FicollPaque sedimentation or in lymphoblastic leukaemia and CML by sedimentation at I g. Cells were washed twice with culture medium (TC 199, Flow Labs Ltd) and stored (up to 18 months) at -70°C as cell pellets prior to analysis. Of the samples studied, 50 of 56 contained in excess of 70% leukaemic cells, 3 had > 60% and 3 had > 50%.
Lysosomal enzyme activities were measured on sonicated cell extracts as reported earlier. 4 Enzyme assays were carried out under optimal conditions using standard fluorogenic substrates in the form of 4-methylumbelliferone conjugates. Protein concentrations were determined as described earlier. 4 Isoelectric focusing was carried out in a linear sucrose gradient containing Triton X 100 (1 g/l) and ampholine (LKB Ltd) in the range pH 3 5-10. " Up to six columns of 10 ml working capacity could be run simultaneously and 40 fractions were collected from each column. The pH of each fraction was recorded immediately at 5°C and enzyme activities were measured as indicated above.
Results
Acid hydrolase activities of leukaemic and nonleukaemic cells are shown in Table 1 (Fig. 2) . The size of the /3-hexosaminidase A peak was generally twice that of /3-hexosaminidase B, mean ratio of peak heights being 2-0 units (Table 2 ). In all samples studied from patients with AML, the activity of the B component was markedly reduced (Table 2) 
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a-mannosidase and ,3-glucuronidase activity were commonly found in cells from patients with acute forms of both myeloid/monocytic and lymphoid leukaemia, as indicated in Table 3 . The type of abnormalitv was similar in all cases (both myeloid and lvmphoid types) and resulted in an apparent shift of enzyme activity to a more anodic position. Foramannosidase the major peak shifted from pl 6 2 to pI 5 1 and for ,-glucuronidase the major peak shifted from pl 7 9 to pl 7-0 (Fig. 2) . The most consistent changes were seen for AML patients where abnormal a-mannosidase profiles were seen in 6/7 patients, and abnormalfl-glucuronidase profiles were found in 7/7 patients. Activity profiles for a-fucosidase were also studied in all cases; a normal profile was observed in all but one case (T-ALL patient) where the major enzyme shifted from pl 6-2 to pl 5 2. similar to the change observed for a-mannosidase. The abnormal expression of lysosomal enzyme profiles in these leukaemic patients did not appear to correlate with other markers studied nor with the clinical expression of the disease.
Discussion
Previous studies from this laboratory'4 and elsewhere'2 3 have concentrated on patterns of lysosomal enzyme expression in acute forms of childhood lymphoblastic leukaemia. In the current report, studies have been extended to cover other forms of leukaemia in adults. Although cytochemical analyses of lysosomal enzyme activities56 are fairly widely used, quantitative assays which may complement these, have been less extensively studied. Studies on different populations of normal peripheral leucocytes'6-'8 have suggested that specific cells possess characteristic levels of hydrolase activity. Many lysosomal enzyme activities, including ,l3-hexosaminidase, /3-glucuronidase and acid phosphatase, but excluding a-mannosidase, were found'6 to be high in normal monocytes. In leukaemic monocytes activities were somewhat higher in one report'0 but in our study activities, particularly of Bhexosaminidase and a-mannosidase, were markedly raised. High a-mannosidase activity in these cells may thus reflect a change associated with malignancy rather than a monocytic characteristic. A similar biochemical change associated with malignancy may occur in B-CLL lymphocytes. Compared with T lymphocytes, normal B lymphocytes have been reported" '9 to possess slightly lower activities of ,B-hexosaminidase, ,B-glucuronidase and acid phosphatase but rather higher a-mannosidase activities. Yet a-mannosidase activity was markedly (p <0 001) lower in B-CLL lymphocytes in our study, and others.""" Low activities of /3-hexosaminidase and /-glucuronidase in B-CLL lymphocytes confirm previous biochemical7 1920 and cytochemical820 analysis, although our findings would suggest a general depression of lysosomal activity in these cells, as suggested by EM studies.' Activities in T-CLL lymphocytes were not depressed to the same extent in the three patients studied here and one elsewhere.20 In all lymphoid leukaemias, apart from 3-hexosaminidase, the activities of lysosomal enzymes were somewhat lower than those of control cells (Table 1) ; a similar finding has been reported by others. " To characterise further the nature of lysosomal enzyme activity in leukaemic cells, enzyme components were separated by isoelectric focusing. It has been established'2 '4 that intermediate forms of 3- hexosaminidase activity are expressed in lymphoblasts of most (approx. 80%) cases of childhood non-T, non-B ALL. In the current study intermediate components were identified in only one third of adults with non-T, non-B ALL (Table 3) . No adults with B-CLL expressed abnormal enzyme patterns despite having significantly lowered enzyme activities.
One patient with T-CLL had an abnormal j3,hexosaminidase profile which was similar to the non-T, non-B ALL pattern. However in one T-ALL adult, all four hydrolase profiles were clearly abnormal; intermediate forms of /3-hexosaminidase and anodic forms of a-mannosidase (pl 4 9), a-fucosidase (pl 5 2) and 3-glucuronidase (pl 7 0) activities were present. This patient who was in relapse was classified as having T-ALL based on focal acid phosphatase activity, positive reactions with OKT3 and OKT6 and the presence of TdT at a level of 91 units/108 cells.
Anodic forms of a-mannosidase were commonly 1004 found (Table 3) in acute leukaemias of both lymphoid or myeloid origin but not in the chronic leukaemias studied. These enzymes may therefore reflect a biochemical event associated with acute forms of malignancy in these cells rather than that of a specific cell marker. Previous studies" failed to recognise abnormal a-mannosidase profiles in three children with AML, although abnormal a-mannosidase profiles were seen in those non-T, non-B ALL patients whose cells expressed intermediate ,B-hexosaminidase activity. In this study abnormal a-mannosidase profiles in lymphoid leukaemias appeared identical to those in myeloid or monocytic forms of leukaemia.
Although intermediate forms of f3-hexosaminidase were seen in some lymphoid leukaemias, these components were never found in the non-lymphoid leukaemias. But within this latter group, specific patterns of ,B-hexosaminidase expression were identified as a low B component compared with the A component (see Table 2 ). The nature of this abnormality is not known particularly since abnormal profiles did not correlate with specific activities. Precisely why lysosomal enzyme activities or patterns of expression are altered in leukaemia is not defined by these or other studies. However. Iysosomal enzymes are glycoprotein in nature and a number of changes involving the oligosaccharide structure of glycoproteins2 22 and glycolipids23 24 have been associated with forms of malignancy and cellular differentiation. Lysosomal enzymes may undergo similar changes; for example, abnormal sialylation may result in altered isoelectric points of enzymes. Studies of lysosomal enzymes may therefore provide a useful means of studying oligosaccharide abnormalities associated with malignancy whilst at the same time provide useful enzyme markers in leukaemia.
